Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 3, 2026
Nanobac Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | 2002 |
|---|---|---|---|---|---|---|
Period Ending | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 | 2002 |
| Cash & Equivalents | 0 | 0.04 | 0.01 | 0.02 | 0.05 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0.04 | 0.01 | 0.02 | 0.05 | Upgrade
|
| Cash Growth | -90.04% | 340.17% | -49.88% | -64.01% | - | Upgrade
|
| Receivables | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Inventory | 0.01 | 0.07 | 0.12 | 0.07 | 0.02 | Upgrade
|
| Prepaid Expenses | 0.01 | 0.02 | 0.04 | 0.02 | - | Upgrade
|
| Other Current Assets | - | - | - | - | 0.01 | Upgrade
|
| Total Current Assets | 0.03 | 0.13 | 0.17 | 0.12 | 0.09 | Upgrade
|
| Property, Plant & Equipment | 0.04 | 0.06 | 0.11 | 0.12 | 0.14 | Upgrade
|
| Goodwill | 3.62 | 3.62 | 3.62 | 3.62 | 5.82 | Upgrade
|
| Other Intangible Assets | 3.53 | 3.96 | 5.05 | 5.76 | 2.14 | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.06 | 0.02 | 0.07 | 0.07 | Upgrade
|
| Total Assets | 7.22 | 7.82 | 8.97 | 9.68 | 8.24 | Upgrade
|
| Accounts Payable | 0.98 | 0.41 | 0.31 | 0.65 | 0.75 | Upgrade
|
| Accrued Expenses | 0.77 | 0.52 | 0.84 | 0.39 | 0.37 | Upgrade
|
| Short-Term Debt | 4.12 | 5.37 | 2.49 | 0.26 | 5.73 | Upgrade
|
| Other Current Liabilities | 0.88 | - | 0.03 | 0.02 | - | Upgrade
|
| Total Current Liabilities | 6.75 | 6.3 | 3.67 | 1.3 | 6.85 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 2.2 | Upgrade
|
| Other Long-Term Liabilities | 2.84 | 2.84 | 2.84 | 2.27 | - | Upgrade
|
| Total Liabilities | 9.58 | 9.14 | 6.51 | 3.57 | 9.05 | Upgrade
|
| Common Stock | 22.87 | 17.26 | 16.31 | 16.3 | 4.23 | Upgrade
|
| Additional Paid-In Capital | 3.8 | 3.8 | 3.5 | 3.54 | - | Upgrade
|
| Retained Earnings | -28.93 | -22.35 | -17.38 | -13.69 | -5.17 | Upgrade
|
| Comprehensive Income & Other | -0.11 | -0.02 | 0.03 | -0.03 | -0.22 | Upgrade
|
| Total Common Equity | -2.36 | -1.31 | 2.46 | 6.11 | -1.16 | Upgrade
|
| Shareholders' Equity | -2.36 | -1.31 | 2.46 | 6.11 | -0.81 | Upgrade
|
| Total Liabilities & Equity | 7.22 | 7.82 | 8.97 | 9.68 | 8.24 | Upgrade
|
| Total Debt | 4.12 | 5.37 | 2.49 | 0.26 | 5.73 | Upgrade
|
| Net Cash (Debt) | -4.12 | -5.33 | -2.48 | -0.24 | -5.68 | Upgrade
|
| Net Cash Per Share | -0.02 | -0.03 | -0.01 | -0.00 | -0.08 | Upgrade
|
| Filing Date Shares Outstanding | 249.51 | 247.48 | 193.51 | 189.01 | 139.52 | Upgrade
|
| Total Common Shares Outstanding | 249.51 | 205.47 | 189.01 | 187.24 | 99.97 | Upgrade
|
| Working Capital | -6.71 | -6.17 | -3.5 | -1.19 | -6.76 | Upgrade
|
| Book Value Per Share | -0.01 | -0.01 | 0.01 | 0.03 | -0.01 | Upgrade
|
| Tangible Book Value | -9.5 | -8.89 | -6.2 | -3.26 | -9.11 | Upgrade
|
| Tangible Book Value Per Share | -0.04 | -0.04 | -0.03 | -0.02 | -0.09 | Upgrade
|
| Buildings | - | - | 0.05 | 0.05 | 0.05 | Upgrade
|
| Machinery | 0.15 | 0.17 | 0.18 | 0.15 | 0.13 | Upgrade
|
| Leasehold Improvements | - | - | 0.05 | 0.05 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.